Texas Lifts Pause on Johnson & Johnson COVID-19 vaccine


Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.

CDC & FDA Press Release


The Texas Department of State Health Services has notified vaccine providers in the state that they should resume using the Johnson & Johnson COVID-19 vaccine. The announcement comes after a thorough safety review and a Centers for Disease Control and Prevention advisory committee’s determination that the vaccine’s benefits outweigh its risks.

DSHS has shared information on how to treat TTS with health care professionals across the state, and they should review the updated Fact Sheet for Healthcare Providers. Vaccine providers should share information from the updated Fact Sheet for Recipients and Caregivers with everyone who receives the Johnson & Johnson vaccine. 

DSHS' press release.